Postoperative hypofractionated intensity-modulated radiotherapy endometrial cancer

Not Applicable

Recruiting

• Conditions: Neoplasms

• Registration Number: KCT0008050
• Lead Sponsor: Samsung Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 10 January 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 92

Inclusion Criteria

1) Histologically diagnosed endometrioid type patient
2) Patients who underwent hysterectomy and surgical staging
3) Patient who corresponds to FIGO Stage III in surgical pathology examination
4) Patients undergoing or planning to undergo systemic chemotherapy
5) Adults between 20 and 80 years of age
6) Whole body performance before participation in the study was ECOG 0-1
7) When the patient voluntarily writes a consent form

Exclusion Criteria

1) Patients with distant metastases
2) Patients who have previously received pelvic radiation therapy
3) In case of untreated serious acute disease other than endometrial cancer
4) In case of recurrence or recurrence within 5 years after diagnosis of other cancers except for thyroid cancer and skin cancer

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Disease-free survival rate when hypofractionated intensity modulated radiotherapy is applied after surgery for endometrial cancer

Secondary Outcome Measures

Name	Time	Method
Overall survival rate when hypofractionated intensity modulated radiotherapy is applied after surgery for endometrial cancer;Acute grade 3 or higher side effects when hypofractionated intensity-modulated radiotherapy is applied after surgery for endometrial cancer;Chroni grade 3 or higher side effects when hypofractionated intensity-modulated radiotherapy is applied after surgery for endometrial cancer